Cengiz Tarhan,英国伦敦大学商业化公司总监。Having trained as an accountant, after a spell at University of London Cengiz joined the Royal Free Hospital School of Medicine (RFHSM) in 1989. In 1993 he was appointed as Finance Director for RFHSM and then continued as Director of Financial and Business Affairs for the Medical School on its merger with UCL in 1998. Cengiz established Freemedic PLC (now UCL Business PLC (UCLB)) as the commercial arm of RFHSM in 1993 and formally transferred from his UCL role to the position of Managing Director for UCLB in 2004. Over the years he has been involved in many licences and spin-outs including PolyMASC Pharmaceuticals PLC, one of the first university spin-outs to float on the AIM in 1995, Medic to Medic Ltd (creators of the Map of Medicine) which was sold to Informa PLC in 2005 and Stanmore Implants Worldwide Limited which was acquired by Abingworth and MDY Healthcare in February 2008. Cengiz also acts as a Director for a number of UCLB’s spinout companies, including Pentraxin Therapeutics Limited, Evexar Medical Limited and the Bloomsbury BioSeed Fund as well as acting as advisor to a number of international technology transfer organisations and universities.
我们专注于根据您的具体需求(包括演讲议题、会议日期及活动预算等),为您精准匹配各领域专业嘉宾。为高效服务,建议您提前准备好详细活动信息,并拨打客服电话:18911802888(工作日9:00-18:00)。
温馨提示:本服务仅限嘉宾邀约相关事宜,其他需求暂不处理,感谢您的理解与配合。